WO2009044009A3 - Utilisation du 4-azacholest-4-ène n-oxide ou de ses dérivés comme antioxydants - Google Patents

Utilisation du 4-azacholest-4-ène n-oxide ou de ses dérivés comme antioxydants Download PDF

Info

Publication number
WO2009044009A3
WO2009044009A3 PCT/FR2008/001100 FR2008001100W WO2009044009A3 WO 2009044009 A3 WO2009044009 A3 WO 2009044009A3 FR 2008001100 W FR2008001100 W FR 2008001100W WO 2009044009 A3 WO2009044009 A3 WO 2009044009A3
Authority
WO
WIPO (PCT)
Prior art keywords
azacholest
ene
antioxidants
derivatives
oxide
Prior art date
Application number
PCT/FR2008/001100
Other languages
English (en)
Other versions
WO2009044009A2 (fr
Inventor
Rebecca Pruss
Cyrille Drouot
Original Assignee
Trophos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos filed Critical Trophos
Publication of WO2009044009A2 publication Critical patent/WO2009044009A2/fr
Publication of WO2009044009A3 publication Critical patent/WO2009044009A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne l'utilisation du 4-azacholest-4-ène N-oxide ou d'au moins un de ses dérivés comme antioxydants dans les domaines cosmétiques et alimentaires, et comme conservateurs antioxydant utilisables notamment dans des produits cosmétiques, alimentaires, et pharmaceutiques.
PCT/FR2008/001100 2007-07-25 2008-07-24 Utilisation du 4-azacholest-4-ène n-oxide ou de ses dérivés comme antioxydants WO2009044009A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705427 2007-07-25
FR0705427A FR2919181A1 (fr) 2007-07-25 2007-07-25 Utilisation du 4-azacholest-4-ene n-oxide ou de ses derives comme antioxydants

Publications (2)

Publication Number Publication Date
WO2009044009A2 WO2009044009A2 (fr) 2009-04-09
WO2009044009A3 true WO2009044009A3 (fr) 2009-11-05

Family

ID=39156847

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/001100 WO2009044009A2 (fr) 2007-07-25 2008-07-24 Utilisation du 4-azacholest-4-ène n-oxide ou de ses dérivés comme antioxydants

Country Status (2)

Country Link
FR (1) FR2919181A1 (fr)
WO (1) WO2009044009A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527807A (en) * 1992-05-20 1996-06-18 Merck & Co., Inc. 7β-substituted-4-aza-5α-cholestan-3-ones as 5α reductase inhibitors useful in the prevention and treatment of hyperandrogenetic disorders
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
EP1295600A2 (fr) * 2001-09-21 2003-03-26 Dr. Kade Pharmazeutische Fabrik GmbH Médicament à base de gestagenes à application dermique
FR2907783A1 (fr) * 2006-10-30 2008-05-02 Trophos Sa Nouveaux composes chimiques, leurs procedes de synthese et leur utilisation a titre de medicament, particulierement a titre de medicament cytoprotecteur, neuroprotecteur ou cardioprotecteur

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527807A (en) * 1992-05-20 1996-06-18 Merck & Co., Inc. 7β-substituted-4-aza-5α-cholestan-3-ones as 5α reductase inhibitors useful in the prevention and treatment of hyperandrogenetic disorders
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
EP1295600A2 (fr) * 2001-09-21 2003-03-26 Dr. Kade Pharmazeutische Fabrik GmbH Médicament à base de gestagenes à application dermique
FR2907783A1 (fr) * 2006-10-30 2008-05-02 Trophos Sa Nouveaux composes chimiques, leurs procedes de synthese et leur utilisation a titre de medicament, particulierement a titre de medicament cytoprotecteur, neuroprotecteur ou cardioprotecteur

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BURBIEL J ET AL: "Azasteroids as antifungals", September 2003, STEROIDS, BUTTERWORTH-HEINEMANN, STONEHAM, MA, US, PAGE(S) 587-594, ISSN: 0039-128X, XP004453284 *
KRSTIC ET AL: "Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities", STEROIDS, ELSEVIER SCIENCE PUBLISHERS, NEW YORK, NY, US, vol. 72, no. 5, 21 April 2007 (2007-04-21), pages 406 - 414, XP022041669, ISSN: 0039-128X *
PRADHAN ET AL: "Unusual Reactions of Steroidal and Non-Steroidal 1,5-Dioximes. Stereochemistry and Mechanism of Formation of N-Hydroxy-Piperidine Analogues", 1989, HETEROCYCLES, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, PAGE(S) 813-839, ISSN: 0385-5414, XP009083854 *

Also Published As

Publication number Publication date
WO2009044009A2 (fr) 2009-04-09
FR2919181A1 (fr) 2009-01-30

Similar Documents

Publication Publication Date Title
HK1252943A1 (zh) 可用於食品、飲食補充劑、化妝品和藥物製劑的呈現多種協同抗氧化劑活性的植物複合物
WO2011073437A3 (fr) Compositions cosmétiques ou dermatologiques à base de bactériocines et de prébiotiques
PL2224973T3 (pl) Środki konserwujące do kosmetyków, środków do pielęgnacji ciała i kompozycji farmaceutycznych
WO2013122931A3 (fr) Utilisation topique d'un agent prébiotique commensal dermique et compositions le contenant
WO2011148328A3 (fr) Procédé cosmétique pour le maquillage et/ou le soin de la peau et/ou des lèvres
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
IL221146A (en) History of Pyridine 2,5- Two-Converted, Pharmaceutical Preparations Containing Them, and Their Use in the Preparation of Drugs for the Prevention and Treatment of Cancer
EP2168570A3 (fr) Extraits d'isochrysis sp.
WO2009050580A8 (fr) Composition destinee a la regulation du metabolism des lipides
IL196133A0 (en) Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
PL2173195T3 (pl) Biomasa wzbogacona w cynk, sposób jej wytwarzania oraz zawierające ją produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne
FR2953135B1 (fr) Extrait de graines d'acacia macrostachya et compositions cosmetiques, pharmaceutiques, dermatologiques, nutraceutiques ou alimentaires le comprenant
WO2012074930A3 (fr) Composition à faible éructation et méthodes de traitement et/ou de prévention de maladie cardiovasculaire chez un sujet présentant une allergie/hypersensibilité aux poissons
EP2380552A4 (fr) Composition d'émulsion, et aliment et cosmétique contenant ladite composition d'émulsion
WO2011000866A3 (fr) Verres à composants multiples destinés à être utilisés dans des produits de soin
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
WO2011106423A3 (fr) Formulations à base d'acai et d'iridoïdes
WO2008155061A3 (fr) Préparations cosmétiques contenant des hydrocarbures
WO2009093104A3 (fr) Utilisation d'huile d'olive transestérifiée dans le domaine cosmétique
IL212567A (en) Zaxanthin, alone or in combination with rutin, spermidine, or both, for the treatment of scalp disorders, use of zaxanthin, alone or in combination with rutin, spermidine or both, for the preparation of a medicinal or cosmetic or nutritional preparation for the treatment of scalp, and a medicinal, cosmetic or nutritional preparation containing Alone or in a mixture with routine, spermidine, or both
EP3694330A4 (fr) Dérivés d'indazolyl-spiro [2.2]pentane-carbonitrile en tant qu'inhibiteurs de lrrk2, compositions pharmaceutiques et leurs utilisations
EP3694331A4 (fr) Dérivés d'indazolyl-spiro [2,3]hexane-carbonitrile comme inhibiteurs de lrrk2, compositions pharmaceutiques, et utilisations de ceux-ci
WO2007137297A3 (fr) Aliments et boissons contenant des additifs
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2009044010A3 (fr) Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08835356

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12010500211

Country of ref document: PH

122 Ep: pct application non-entry in european phase

Ref document number: 08835356

Country of ref document: EP

Kind code of ref document: A2